Article Sidebar
Date Published:
17/06/2022
Abstract Views: 639
Views PDF: 528
Views PDF: 528
Issue
Section
Các bài báo
How to Cite
Thị Minh Thúy, N., & Thị Dung, H. . (2022). ADHERENCE OF ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION AT NGHE AN GENERAL FRIENDSHIP HOSPITAL. Vietnam Medical Journal, 513(2). https://doi.org/10.51298/vmj.v513i2.2445
ADHERENCE OF ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION AT NGHE AN GENERAL FRIENDSHIP HOSPITAL
Main Article Content
Abstract
Objectives: Adherence of antiplatelet therapy after PCI. Methods: cross-sectional study of ambulatory patients who had underwent PCI were evaluated. Results: between 04/2021–10/2021, there were 155 patients (male 70.3%, mean age 67,81± 11,02). Low, average, high adherence were 34.8%, 51.6%, 13.5% respectively. Treatment cost was significantly related to medical adherence (OR = 2.164, CI 95% 1.014 – 4.620, p=0.04). Conclusions: Low, average, high adherence of antiplatelet therapy, antidyslipidemia therapy were 34.8%, 51.6%, 13.5% . Treatment cost was significantly related to medical adherence.
Article Details
References
1. Võ Thị Dễ (2010). Sự tuân thủ điều trị thuốc chống kết tập tiểu cầu của bệnh nhân đặt stent động mạch vành tại Bệnh viện Chợ Rẫy và bệnh viện đại học Y Dược thành phố Hồ Chí Minnh năm 2007 -2008. Y học thục hành. 730: p. 34-36.
2. Hoàng Quốc Hòa (2010). Đánh giá sử dụng thuốc sau can thiệp mạch vành. Y Học TP Hồ Chí Minh. 14(2): p. 148-152.
3. Paul Muntner, et al. (2011). Predictors of clopidogrel adherence following percutaneous coronary intervention. Am J Cardiol. 108(6): p. 822-827.
4. Robin Mathews, et al. (2012). Medication nonadherence among patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights from the TRANSLATE-ACS study. J Am Coll Cardiol. 59(13): p. 1814.
5. P.T. O'Gara, et al. (2013). 2013 ACCF/AHA guideline for the Management of ST - Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation. 127: p. e362-e425.
6. R. Mehran, et al. (2013). Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet. 13.
7. Stephan Windecker, et al. (2014). 2014 ESC/ EACTS Guidelines on myocardial revascularization. European Heart Journal. 35: p. 2541-2619.
8. J. Matthews, et al. (2014). Adherence to dual antiplatelet therapy after coronary stenting: a systematic review. Clin Cardiol. 37(8): p. 505-513.
2. Hoàng Quốc Hòa (2010). Đánh giá sử dụng thuốc sau can thiệp mạch vành. Y Học TP Hồ Chí Minh. 14(2): p. 148-152.
3. Paul Muntner, et al. (2011). Predictors of clopidogrel adherence following percutaneous coronary intervention. Am J Cardiol. 108(6): p. 822-827.
4. Robin Mathews, et al. (2012). Medication nonadherence among patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights from the TRANSLATE-ACS study. J Am Coll Cardiol. 59(13): p. 1814.
5. P.T. O'Gara, et al. (2013). 2013 ACCF/AHA guideline for the Management of ST - Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation. 127: p. e362-e425.
6. R. Mehran, et al. (2013). Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet. 13.
7. Stephan Windecker, et al. (2014). 2014 ESC/ EACTS Guidelines on myocardial revascularization. European Heart Journal. 35: p. 2541-2619.
8. J. Matthews, et al. (2014). Adherence to dual antiplatelet therapy after coronary stenting: a systematic review. Clin Cardiol. 37(8): p. 505-513.